FDA Inspection 765182 — Berkeley Biologics LLC

Berkeley Biologics LLC — FEI 1000100754

The FDA completed an inspection of Berkeley Biologics LLC on Feb 17, 2012 in Richmond, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 17, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Richmond, CA (United States)

Citations

IDCFRDescription
1230921 CFR 1271.160(a)Program is appropriate for the HCT/Ps
1239821 CFR 1271.230(a)Validation & approval--established procedures
1241121 CFR 1271.260(a)Contamination, mix ups, improper release

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.